BRCA1 positive cases more often had Nestin positive tumours, compared with cases without BRCA1 germline mutations, OR (odds ratio) 8.7 (p < 0.0005, Series III) (Table 1), with a sensitivity of 62% and specificity of 84%. Here, BRCA1 is linked to neoplasm.